Viewing StudyNCT00093587



Ignite Creation Date: 2024-05-05 @ 11:38 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00093587
Status: UNKNOWN
Last Update Posted: 2013-11-06
First Post: 2004-10-06

Brief Title: Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
Sponsor: Jonsson Comprehensive Cancer Center
Organization: National Cancer Institute NCI

Organization Data

Organization: National Cancer Institute NCI
Class: NIH
Study ID: CDR0000389241
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Jonsson Comprehensive Cancer Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH